MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric A β25-35 -induced anxiety and cognitive deficits in a mouse model.

CONCLUSIONS: These results reveal MGCD0103 could be a potential therapeutic agent against AD. PMID: 29978554 [PubMed - as supplied by publisher]
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Tags: CNS Neurosci Ther Source Type: research